Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 25, 2019
[ Mon, Nov 25th 2019
] - WOPRAI
Fri, November 22, 2019
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
[ Fri, Nov 22nd 2019
] - WOPRAI
Thu, November 21, 2019
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
David Lebovitz Maintained (ALNY) at Buy with Increased Target to $141 on, Nov 21st, 2019
David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $124 to $141 on, Nov 21st, 2019.
David has made no other calls on ALNY in the last 4 months.
There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $96 on, Wednesday, September 4th, 2019
These are the ratings of the 2 analyists that currently disagree with David
- Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $145 on, Tuesday, September 3rd, 2019
